C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism.
第一作者:
Cheng,Xu
第一单位:
Institute of Pharmacology and Toxicology, Beijing 100850, China.
作者:
医学主题词
3T3-L1细胞(3T3-L1 Cells);脂细胞(Adipocytes);动物(Animals);血糖(Blood Glucose);细胞分化(Cell Differentiation);细胞系(Cell Line);胆固醇(Cholesterol);糖尿病, 2型(Diabetes Mellitus, Type 2);脂肪酸类, 非酯化(Fatty Acids, Nonesterified);呋喃类(Furans);葡萄糖转运体4型(Glucose Transporter Type 4);肝细胞(Hepatocytes);人类(Humans);胰岛素抗药性(Insulin Resistance);脂类代谢(Lipid Metabolism);脂蛋白脂酶(Lipoprotein Lipase);男(雄)性(Male);小鼠(Mice);恶唑类(Oxazoles);PPARα(PPAR alpha);PPARγ(PPAR gamma);RNA, 信使(RNA, Messenger);甘油三酯类(Triglycerides)
DOI
10.1111/j.1745-7254.2006.00263.x
PMID
16412273
发布时间
2013-11-21
- 浏览44
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



